Oppenheimer Issues Positive Forecast for UnitedHealth Group (NYSE:UNH) Stock Price

UnitedHealth Group (NYSE:UNH) had its price objective upped by Oppenheimer from $385.00 to $405.00 in a research note released on Wednesday,Benzinga reports. The brokerage currently has an outperform rating on the healthcare conglomerate’s stock.

Other equities analysts also recently issued reports about the stock. Morgan Stanley dropped their price target on shares of UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a research note on Friday, January 23rd. KeyCorp reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Piper Sandler reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. Raymond James Financial upgraded shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price objective for the company in a report on Wednesday, April 1st. Finally, HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price objective for the company in a report on Tuesday, April 7th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $377.68.

UnitedHealth Group Trading Up 2.2%

NYSE UNH opened at $353.51 on Wednesday. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $438.85. The company has a current ratio of 0.80, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $320.88 billion, a PE ratio of 26.70, a price-to-earnings-growth ratio of 1.53 and a beta of 0.40. The firm’s fifty day simple moving average is $290.76 and its 200-day simple moving average is $317.09.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The business had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. During the same period in the prior year, the business posted $7.20 earnings per share. UnitedHealth Group’s revenue for the quarter was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group will post 18.43 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s dividend payout ratio is 67.02%.

Institutional Investors Weigh In On UnitedHealth Group

A number of hedge funds have recently bought and sold shares of UNH. Brighton Jones LLC lifted its stake in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares during the period. CMT Capital Markets Trading GmbH bought a new stake in shares of UnitedHealth Group in the second quarter valued at about $340,000. Flow Traders U.S. LLC bought a new stake in shares of UnitedHealth Group in the second quarter valued at about $356,000. Finally, Jump Financial LLC bought a new stake in shares of UnitedHealth Group in the second quarter valued at about $377,000. 87.86% of the stock is currently owned by institutional investors.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and raised guidance — UNH reported Q1 adjusted EPS of $7.23 (vs. consensus ~$6.76) and revenue of ~$111.7B, and raised FY‑2026 adjusted EPS guidance to above $18.25, citing improved management of medical costs. This is the main catalyst for the rally. Business Wire — Q1 Results
• Positive Sentiment: Analyst upgrades and price‑target increases — Multiple firms (Argus, RBC, Oppenheimer, Wells Fargo, Morgan Stanley, Jefferies, etc.) raised ratings or targets after the report, adding upward pressure as sell‑side momentum attracts buyers. 247wallst — Analyst Upgrades
• Positive Sentiment: AI & operational initiatives — Management flagged a meaningful AI investment (and Optum Real transaction scale), which investors view as a durable margin/efficiency tailwind if deployment scales as planned. That narrative supports higher multiple assumptions. Yahoo Finance — Q1 Deep Dive (AI)
• Positive Sentiment: Bullish options flow — Unusual activity: ~164k call options traded (≈30% above average), signaling short‑term bullish positioning from traders and institutional players.
• Neutral Sentiment: Sector sentiment spillover — UNH’s beat dragged peers higher (CVS, Humana, Centene); positive industry momentum can amplify the stock move but doesn’t change UNH’s fundamentals. Yahoo — Sector Impact
• Negative Sentiment: Ongoing risks remain — Management warned of challenges around a Medicare obesity‑drug pilot and cautioned that medical‑cost dynamics are still the key risk; if costs reaccelerate, margins and guidance could reverse. Reuters — Medicare Obesity Drug Pilot Challenges

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.